Downloads provided by UsageCounts
pmid: 33919103
pmc: PMC8143127
handle: 11441/125813 , 2445/189350 , 10261/261474 , 20.500.12530/59687 , 10668/17675 , 11351/6706
pmid: 33919103
pmc: PMC8143127
handle: 11441/125813 , 2445/189350 , 10261/261474 , 20.500.12530/59687 , 10668/17675 , 11351/6706
This retrospective, multicenter observational study aimed to describe the outcomes of surgical and medical treatment of C. acnes-related prosthetic joint infection (PJI) and the potential benefit of rifampin-based therapies. Patients with C. acnes-related PJI who were diagnosed and treated between January 2003 and December 2016 were included. We analyzed 44 patients with C. acnes-related PJI (median age, 67.5 years (IQR, 57.3–75.8)); 75% were men. The majority (61.4%) had late chronic infection according to the Tsukayama classification. All patients received surgical treatment, and most antibiotic regimens (43.2%) included β-lactam. Thirty-four patients (87.17%) were cured; five showed relapse. The final outcome (cure vs. relapse) showed a nonsignificant trend toward higher failure frequency among patients with previous prosthesis (OR: 6.89; 95% CI: 0.80–58.90) or prior surgery and infection (OR: 10.67; 95% IC: 1.08–105.28) in the same joint. Patients treated with clindamycin alone had a higher recurrence rate (40.0% vs. 8.8%). Rifampin treatment did not decrease recurrence in patients treated with β-lactams. Prior prosthesis, surgery, or infection in the same joint might be related to recurrence, and rifampin-based combinations do not seem to improve prognosis. Debridement and implant retention appear a safe option for surgical treatment of early PJI.
Prosthetic joint infection, Lactams, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, Terapéutica, ENFERMEDADES::infecciones bacterianas y micosis::infección::infecciones relacionadas con prótesis, Recurrencia, DISEASES::Bacterial Infections and Mycoses::Bacterial Infections::Gram-Positive Bacterial Infections, Prosthesis, RM1-950, Clasificación, Infections, surgical and medical treatment, Article, Surgical and medical treatment, Clindamicina, Recurrence, Acne Vulgaris, <i>Cutibacterium acnes</i>, Malalties bacterianes - Tractament, Medicaments antibacterians - Ús terapèutic, Pròtesis, Desbridamiento, prosthetic joint infection, Other subheadings::Other subheadings::Other subheadings::/drug therapy, DISEASES::Bacterial Infections and Mycoses::Infection::Prosthesis-Related Infections, Cirurgia, Clindamycin, Bacteris anaerobis, Articulacions artificials, Prostheses and Implants, Lactamas, Prognosis, Infeccions, Anti-Bacterial Agents, Anaerobic bacteria, Articulaciones, Debridement, Antibacterianos, CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Anti-Bacterial Agents, ENFERMEDADES::infecciones bacterianas y micosis::infecciones bacterianas::infecciones por bacterias grampositivas, COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antiinfecciosos::antibacterianos, Female, Surgery, Therapeutics. Pharmacology, Cutibacterium acnes, Rifampin
Prosthetic joint infection, Lactams, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, Terapéutica, ENFERMEDADES::infecciones bacterianas y micosis::infección::infecciones relacionadas con prótesis, Recurrencia, DISEASES::Bacterial Infections and Mycoses::Bacterial Infections::Gram-Positive Bacterial Infections, Prosthesis, RM1-950, Clasificación, Infections, surgical and medical treatment, Article, Surgical and medical treatment, Clindamicina, Recurrence, Acne Vulgaris, <i>Cutibacterium acnes</i>, Malalties bacterianes - Tractament, Medicaments antibacterians - Ús terapèutic, Pròtesis, Desbridamiento, prosthetic joint infection, Other subheadings::Other subheadings::Other subheadings::/drug therapy, DISEASES::Bacterial Infections and Mycoses::Infection::Prosthesis-Related Infections, Cirurgia, Clindamycin, Bacteris anaerobis, Articulacions artificials, Prostheses and Implants, Lactamas, Prognosis, Infeccions, Anti-Bacterial Agents, Anaerobic bacteria, Articulaciones, Debridement, Antibacterianos, CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Anti-Bacterial Agents, ENFERMEDADES::infecciones bacterianas y micosis::infecciones bacterianas::infecciones por bacterias grampositivas, COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antiinfecciosos::antibacterianos, Female, Surgery, Therapeutics. Pharmacology, Cutibacterium acnes, Rifampin
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 20 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
| views | 46 | |
| downloads | 52 |

Views provided by UsageCounts
Downloads provided by UsageCounts